Launching Fall 2026

Your skin deserves
the science of
menopause care

RevelleCare is a Canadian telemedicine platform that connects women navigating perimenopause and menopause with licensed healthcare practitioners and a trusted compounding pharmacy — for personalized prescription skincare care, from home. Launching Fall 2026 in Ontario & British Columbia.

+75% epidermal thickness restored
+88% skin elasticity improvement
+38% collagen density increase
12M+ Canadian women in menopause transition Statistics Canada
61–100% wrinkle reduction with topical estrogen Schmidt et al., 1996
1:1 personalized treatment plan — prescribed for your individual needs Every prescription is yours alone
Fall 2026 planned launch in Ontario & British Columbia Phase 1 · Canada

Prescription skincare,
beautifully delivered

When RevelleCare launches in Fall 2026, care will be delivered in three simple steps — from your first consultation to your door.

Complete Your Assessment

You will answer a brief intake about your skin, hormonal health, and goals. Our clinical questionnaire will screen for candidacy in minutes.

Meet Your Practitioner

A licensed Canadian healthcare practitioner will review your profile via telemedicine. If clinically appropriate, they will prescribe your personalized formulation.

Receive & Renew

Your compounded prescription will be dispensed by a licensed Canadian pharmacy and delivered to your door. Ongoing monitoring and renewal will be included.

Please note: RevelleCare is currently in pre-launch development. The service model described above represents our planned offering, pending Health Canada regulatory review, licensed healthcare practitioner partnerships, and compounding pharmacy agreements. No products or services are currently available for purchase or prescription.

Coming Fall 2026

Personalized care,
your prescription

Every treatment plan is prescribed by a licensed Canadian healthcare practitioner based on your individual assessment. If clinically appropriate, your prescription is compounded specifically for you by our licensed pharmacy partner. Not yet available.

RevelleCare Revelle Crème
Prescription Required

Menopausal Skin Changes

Hormonal skin care · Clinician-prescribed

If clinically appropriate after your assessment, your nurse practitioner may prescribe a personalized topical treatment for menopausal skin thinning, dryness, and collagen loss. Each prescription is prepared specifically for you.

Learn more
RevelleCare Night Renewal Crème
Prescription Required

Overnight Skin Renewal

Retinoid-based care · Clinician-prescribed

A clinician-directed nighttime regimen tailored to your skin and stage. Your nurse practitioner selects the appropriate strength for you, including a gentler starter option for first-time users.

Learn more
RevelleCare Radiance Crème
Non-Rx

Radiance Crème

Vitamin B3 · Vitamin C · Vitamin E · Peptides

A high-performance companion for those who prefer non-hormonal support. Antioxidant-rich with collagen-stimulating peptides for visible renewal.

Learn more
RevelleCare Intimate Renewal Crème
Prescription Required

Intimate Wellness

Intimate skin care · Clinician-prescribed

Personalized treatment for menopause-related intimate discomfort and genitourinary symptoms, prescribed by your clinician when medically appropriate and compounded specifically for you.

Learn more

Evidence-Based

Decades of research.
One elegant protocol.

RevelleCare's clinical approach is grounded in peer-reviewed evidence on menopausal skin aging. Your clinician draws on decades of dermatological research to determine the treatment plan that may be right for you.

Explore the Science
+75%

Increase in epidermal thickness with prescription topical estrogen therapy

Moraes et al., 2009

61–100%

Wrinkle reduction with prescription topical estrogen therapy in clinical studies

Schmidt et al., 1996

+88%

Improvement in skin elasticity with prescription topical estrogen therapy

Alloy / Draelos, 2024

+38%

Increase in dermal collagen density with prescription topical estrogen therapy

Fuchs et al., 2003

Michèle Lunney, Founder & CEO of RevelleCare

Our Founder

Michele Lunney

Founder & CEO, RevelleCare

With nearly two decades at the intersection of healthcare, innovation, and highly regulated sectors, Michele built her career around growth strategy, commercialization, and high-value partnerships.

She founded RevelleCare to close the gap in women's healthcare — where prescription-grade skincare meets the real, evolving concerns of women's skin at every stage of life. Clinical precision. Luxury experience. Finally, both.

Why skin changes
during menopause

Estrogen Decline

Estrogen is the primary regulator of skin collagen, hydration, and cell turnover. As levels drop during perimenopause, skin loses up to 30% of its collagen in the first five years.

Barrier Disruption

Reduced estrogen compromises the skin barrier, leading to increased transepidermal water loss, sensitivity, and impaired healing — changes that standard moisturizers cannot fully address.

The Rx Difference

Only prescription-strength topical treatments can act on the dermal receptors responsible for collagen synthesis and elastin production. RevelleCare connects you with a licensed clinician who can prescribe what over-the-counter products simply cannot provide.

Launching Fall 2026

Be the first to know
when we launch

Join The Collective and be notified the moment we open in Ontario & British Columbia. No obligation. No spam.

Launching Fall 2026 · Ontario & British Columbia first · National expansion to follow